These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1790695)

  • 41. Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease.
    Mühlhauser I; Sawicki PT; Berger M
    Diabetologia; 1997 Dec; 40(12):1492-3. PubMed ID: 9447960
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin and oral sulfonylureas in the treatment of diabetes mellitus.
    White JR
    Am Pharm; 1992 Aug; NS32(8):39-43. PubMed ID: 1524021
    [No Abstract]   [Full Text] [Related]  

  • 43. Combined insulin and oral sulfonylureas--how sweet it isn't!
    Ponte CD
    DICP; 1990 Dec; 24(12):1234-5. PubMed ID: 2089839
    [No Abstract]   [Full Text] [Related]  

  • 44. Advantage of insulin lispro in suspected insulin allergy.
    Pánczél P; Hosszúfalusi N; Horváth MM; Horváth A
    Allergy; 2000 Apr; 55(4):409-10. PubMed ID: 10782533
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of non-insulin-dependent diabetes mellitus.
    Williams G
    Lancet; 1994 Jan; 343(8889):95-100. PubMed ID: 7903785
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diagnostic and prognostic value of serum insulin determinations after so-called maximal stimulation in life threatening secondary failure of sulfonylurea therapy].
    Sachse G; Willms B
    Verh Dtsch Ges Inn Med; 1978; (84):1195-7. PubMed ID: 741925
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of noninsulin-dependent diabetes mellitus.
    Zimmerman BR; Service FJ
    Med Clin North Am; 1988 Nov; 72(6):1355-64. PubMed ID: 3054357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic approaches to reducing insulin resistance in patients with noninsulin-dependent diabetes mellitus.
    Reaven GM
    Am J Med; 1983 Jan; 74(1A):109-12. PubMed ID: 6337482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of type II diabetes.
    Nattrass M
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1033-4. PubMed ID: 3083989
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations on the effect of glibenclamide on noninvasive clinical parameters of myocardial ischemia.
    Köppel H; Horn S; Pieber T; Grisold M; Klein W; Gasser R
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):383-5. PubMed ID: 9825184
    [No Abstract]   [Full Text] [Related]  

  • 51. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population.
    Polonsky WH; Hajos TR; Dain MP; Snoek FJ
    Curr Med Res Opin; 2011 Jun; 27(6):1169-74. PubMed ID: 21469914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulfonylurea failure in non-insulin-dependent diabetes mellitus.
    Bell DS
    Am J Med; 1990 Apr; 88(4):446-7. PubMed ID: 2327438
    [No Abstract]   [Full Text] [Related]  

  • 53. Sulphonylureas in the treatment of non-insulin-dependent diabetes.
    Melander A
    Baillieres Clin Endocrinol Metab; 1988 May; 2(2):443-53. PubMed ID: 3075901
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormono-metabolic profiles of patients with diabetes mellitus type 2 and acquired sulfonylurea insensitivity].
    Scionti L; Calafiore R; Calcinaro F; Massi-Benedetti M; Santeusanio F; Brunetti P
    Minerva Endocrinol; 1984; 9(2):253-6. PubMed ID: 6503909
    [No Abstract]   [Full Text] [Related]  

  • 55. Some thoughts on the treatment of non-insulin-dependent diabetes mellitus.
    Somers G; Keymeulen B; Segers O
    Acta Clin Belg; 1993; 48(4):221-7. PubMed ID: 8212973
    [No Abstract]   [Full Text] [Related]  

  • 56. The therapeutic approach to the obese maturity-onset diabetic patient.
    Lipson LG; Lipson M
    Arch Intern Med; 1984 Jan; 144(1):135-8. PubMed ID: 6362593
    [No Abstract]   [Full Text] [Related]  

  • 57. Study on insulin resistance in TCM treatment of noninsulin-dependent diabetes mellitus.
    Xiong M; Zhu Z
    J Tradit Chin Med; 1996 Sep; 16(3):163-7. PubMed ID: 9389111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological insulin resistance due to insulin antibodies developed after cessation of insulin therapy in a patient with type 2 diabetes.
    Hirano M; Arima H; Oiso Y
    Diabetes Care; 2008 Nov; 31(11):e84. PubMed ID: 18955711
    [No Abstract]   [Full Text] [Related]  

  • 59. [Roles of the cAMP sensor Epac2A in insulin secretion].
    Shibasaki T; Seino S
    Nihon Naika Gakkai Zasshi; 2011 May; 100(5):1418-24. PubMed ID: 21702163
    [No Abstract]   [Full Text] [Related]  

  • 60. Do sulfonylurea drugs limit coronary vasodilator reserve?
    Engler RL
    J Am Coll Cardiol; 1998 Jun; 31(7):1698. PubMed ID: 9626854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.